Coya Therapeutics, Inc. (COYA)
$4.47-7.07%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $81M
- Beta
- 0.58
- P/E (TTM)
- -4.18
- Short % float
- 6.79%
- Days to cover
- 7.0
- SI change
- +0.3%
- 1W
- -7.84%
- 1M
- -3.66%
- vs SPY 1W
- -7.70%
- vs SPY 1M
- -6.17%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on COYA?
- LOPJLB’s latest quantitative signal on Coya Therapeutics, Inc. (COYA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is COYA in?
- Coya Therapeutics, Inc. (COYA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Coya Therapeutics, Inc. (COYA) do?
- Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipeline leverages diverse approaches, including biologics designed to enhance Treg activity, Treg-derived exosomes, and personalized autologous Treg cell therapies. Among its lead candidates is COYA 101,…